Use of Systemic Proteasome Inhibition as an Immune-Modulating Agent in Disease

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 7, Iss. 1, 2007-03 ,pp. : 29-34

Bentham Science Publishers

Access to resources Recommend Favorite

Role of Toll-Like Receptors in Immune Responses to Chlamydial Infections

By  

Current Pharmaceutical Design, Vol. 14, Iss. 6, 2008-02 ,pp. : 593-600

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [Hot Topic:Gene Therapy for Modulating Immune/Inflammatory Responses (Guest Editor: Maria Manunta)]

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 6, Iss. 2, 2007-05 ,pp. : 99-99

Bentham Science Publishers

Access to resources Recommend Favorite

Leptin, Immune Responses and Autoimmune Disease. Perspectives on the Use of Leptin Antagonists

By  

Current Pharmaceutical Design, Vol. 11, Iss. 4, 2005-02 ,pp. : 539-548

Bentham Science Publishers

Access to resources Recommend Favorite

Use of Anti-Cancer Drugs, Mitocans, to Enhance the Immune Responses against Tumors

By  

Current Pharmaceutical Biotechnology, Vol. 14, Iss. 3, 2013-03 ,pp. : 357-376

Bentham Science Publishers

Access to resources Recommend Favorite